The effect of human immunodeficiency virus and human papillomavirus strain diversity on the progression of anal squamous intraepithelial lesions

Hum Pathol. 2022 Oct:128:20-30. doi: 10.1016/j.humpath.2022.06.025. Epub 2022 Jul 5.

Abstract

Anal squamous cell carcinoma (SCC) is a human papillomavirus (HPV)-mediated malignancy with increasing incidence. Human immunodeficiency virus (HIV) infection is a significant risk factor for anal SCC; however, it is unknown if HIV infection alters anal lesion progression and HPV strain profile. This study aims to determine whether HIV coinfection is associated with progression of HPV-mediated anal lesions and on their HPV strain diversity. This is a retrospective cohort study of adults with anal squamous intraepithelial lesion (SIL) who presented for anorectal sampling between 2010 and 2019. Using the full cohort, we performed clinicopathologic epidemiologic analysis of HIV coinfection on lesion progression. Using a subset of patients, we conducted molecular analysis of HPV strain diversity as related to HIV status and progression. Our cohort included 2203 individuals, of which 940 (43%) were HIV+. HIV+ status was associated with faster progression at all levels of dysplasia. Our molecular cohort included 329 adults, of which 190 (57.8%) were HIV+. HIV+ status was associated with higher HPV strain diversity (median: 7 [5-9] versus median: 4 [4-6], P < .001). Latent class analysis identified specific HPV strain signatures associated with progression. We demonstrate that HIV+ individuals had faster rates of anal SIL progression and that almost all HPV strains were more prevalent in anal samples from HIV+ adults. Our results imply that HIV+ adults with anal SIL should undergo more frequent screening and obtain HPV genotyping at initial presentation, as it shows value as a biomarker of lesion progression.

Keywords: Anal cancer; Anal dysplasia; HIV; HPV; Squamous cell carcinoma.

MeSH terms

  • Adult
  • Alphapapillomavirus*
  • Anus Neoplasms* / pathology
  • Biomarkers
  • Carcinoma, Squamous Cell* / pathology
  • HIV
  • HIV Infections* / complications
  • Humans
  • Papillomaviridae / genetics
  • Papillomavirus Infections*
  • Prevalence
  • Retrospective Studies
  • Squamous Intraepithelial Lesions*

Substances

  • Biomarkers